Halberd Co. (OTCMKTS:HALB) Short Interest Update

Halberd Co. (OTCMKTS:HALB – Get Free Report) saw a significant increase in short interest in August. As of August 31st, there was short interest totaling 62,846 shares, an increase of ∞ from the August 15th total of 0 shares. Based on an average daily trading volume, of 355,993 shares, the days-to-cover ratio is presently 0.2 days.

Halberd Price Performance

Halberd stock opened at $0.00 on Tuesday. Halberd has a 12-month low of $0.00 and a 12-month high of $0.00.

Get Halberd alerts:

Halberd Company Profile

(Get Free Report)

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Recommended Stories

• Five stocks we like better than Halberd
• Clearance to Climb: Why Allegiant Has Room to Fly
• 3 Defense Stocks Riding the High-Energy Laser Boom
• Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
• Institutional Money Is Pouring Into These 2 Altcoin ETFs

Receive News & Ratings for Halberd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halberd and related companies with MarketBeat.com's FREE daily email newsletter.